Homemade GHK-Cu serums for perimenopause: what the science says

What's this video probably claiming?

Based on the caption and hashtags, @lizarita901 is likely walking viewers through a DIY recipe for a GHK-Cu (copper peptide) serum, positioned as a skin or wellness hack for the perimenopause transition. Creators in this space typically claim GHK-Cu can reverse skin thinning, boost collagen, reduce inflammation, and sometimes gesture at hormonal or systemic benefits. The perimenopause angle is a smart hook because estrogen decline genuinely does accelerate collagen loss, roughly 30% in the first five years after menopause according to Brincat et al. (1987, British Journal of Obstetrics and Gynaecology). Pairing that real biology with a trendy peptide gives the content emotional credibility. Expect claims about "activating stem cells," "resetting skin," or copper peptides "mimicking" some hormonal function. Those are the kinds of phrases that spread fast on TikTok and deserve serious scrutiny.

What does the science actually show?

GHK-Cu is a naturally occurring tripeptide-copper complex with a legitimate research base, which makes it harder to debunk cleanly. Pickart and Margolina (2018, Cosmetics) summarize decades of in vitro and animal data showing GHK-Cu can stimulate collagen and elastin synthesis, activate antioxidant pathways, and modulate TGF-beta signaling. Concentration matters: most published cosmetic studies use 1-5% topical concentrations. A small controlled trial by Leyden et al. (1991, Skin Pharmacology) found measurable improvement in skin density over 12 weeks, though the sample size was modest. The catch is that almost none of this work is in menopausal women specifically, and virtually none of it is randomized, blinded, and large enough to draw firm conclusions. In vitro collagen activation does not automatically translate to clinical skin improvement in a 48-year-old human. The gap between petri dish and person is where most of these claims quietly collapse.

Where does the social media noise diverge from clinical reality?

Several divergences are worth naming directly. First, the DIY formulation problem: GHK-Cu is sensitive to pH, oxidation, and incompatible actives like vitamin C at low pH. A homemade serum with no stability testing could be inert or, in worse cases, irritating due to free copper ion release. Second, the perimenopause framing implies systemic or hormonal benefit. There is no peer-reviewed evidence that topical GHK-Cu affects estrogen levels, FSH, or any hormonal marker in perimenopausal women. Claiming or implying it does would be misleading. Third, creators in this space frequently conflate injectable and topical GHK-Cu research. Systemic peptide studies use entirely different delivery mechanisms and doses than a face serum, and those studies are themselves preliminary. The FDA has not approved GHK-Cu for any medical indication. Blurring these lines is a pattern across peptide content and it consistently overstates what topical products can do.

What should you actually know?

GHK-Cu is one of the better-researched cosmetic peptides, and topical use at appropriate concentrations is considered low-risk for most people. That's the honest good news. The honest bad news is that a homemade serum carries real formulation risks, the perimenopause-specific evidence simply does not exist yet, and no topical peptide replaces the evidence base behind hormone therapy for managing perimenopausal skin changes. If skin thinning during perimenopause is a genuine concern, the conversation worth having is with a clinician who can assess whether low-dose topical estrogen, systemic HRT, or adjunct cosmetic approaches make sense for your situation. Retinoids, for instance, have a far stronger randomized controlled trial record for postmenopausal skin than copper peptides do. GHK-Cu may be a useful addition to a skincare routine. It should not be positioned as a perimenopause treatment.